Why Is TG Therapeutics Stock Gaining Tuesday?

TG Therapeutics, Inc. (NASDAQ:TGTX) stock is up on Tuesday as the company announced positive topline Phase 1 data for its subcutaneous BRIUMVI (ublituximab-xiiy) for myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder that causes weakness and rapid...